Healthcare technology and consulting firm iMedicor, Nanuet, N.Y., has acquired iPenMD in an all-stock transaction with a private equity firm, saying the company's product will help physicians translate hand-written paper files automatically into electronic health records.
Health IT firm iMedicor acquires iPenMD
The seller, private equity firm JTJ Capital, received 9 million shares in the deal, which iMedicor CEO Fred Zolla said was equivalent to roughly $600,000. iMedicor is traded on the over-the-counter market under the ticker symbol VMCI.
Zolla said iPenMD's product is a “digital pen system” that reads a physician's handwriting and converts patient chart notes into editable text that flows into the correct fields in any EHR system that is certified for meaningful use.
Letter
to the
Editor
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.
Sponsored Content